Significance of MIB-1 Staining Indices in Meningiomas: Comparison of Two Counting Methods
暂无分享,去创建一个
Masayuki Nakajima | S. Nakasu | M. Nakajima | H. Okabe | Hidetoshi Okabe | Satoshi Nakasu | Dong Hou Li | Masayuki Matsuda | Dongchuan Li | Masayuki Matsuda
[1] C. Cornelisse,et al. Nuclear distribution of the Ki-67 antigen during the cell cycle: comparison with growth fraction in human breast cancer cells. , 1989, Cancer research.
[2] L. Langford,et al. Comparison of MIB-1 (Ki-67) antigen and bromodeoxyuridine proliferation indices in meningiomas. , 1996, Human pathology.
[3] 大田 正流. MIB1 staining index and scoring of histologic features in meningioma , 1995 .
[4] A. Probst,et al. Prognostic significance of MIB-1, p53, and bcl-2 immunoreactivity in meningiomas. , 1998, Human pathology.
[5] H Stein,et al. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. , 1984, Journal of immunology.
[6] J. Gerdes,et al. Immunohistological detection of tumour growth fraction (Ki-67 antigen) in formalin-fixed and routinely processed tissues. , 1992, The Journal of pathology.
[7] R. Prayson,et al. MIB-1 labeling indices in benign, aggressive, and malignant meningiomas: a study of 90 tumors. , 1998, Human pathology.
[8] A. Asai,et al. Clinical and histopathological analysis of proliferative potentials of recurrent and non-recurrent meningiomas , 1996, Acta Neuropathologica.
[9] Johannes Gerdes,et al. Monoclonal antibodies against recombinant parts of the Ki‐67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave‐processed formalin‐fixed paraffin sections , 1992, The Journal of pathology.
[10] Charles B. Wilson,et al. Proliferative potential of brain tumors. Analyses with Ki‐67 and anti‐dna polymerase alpha monoclonal antibodies, bromodeoxyuridine labeling, and nucleolar organizer region counts , 1993, Cancer.
[11] J. Hendricks,et al. Effect of fixation time and microwave oven heating time on retrieval of the Ki-67 antigen from paraffin-embedded tissue. , 1993, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[12] S. Nakasu,et al. p53 accumulation and apoptosis in embolized meningiomas , 1997, Acta Neuropathologica.
[13] G. van Melle,et al. The implications of the heterogeneous distribution of Ki-67 labelled cells in meningiomas. , 1989, British journal of neurosurgery.
[14] R. Prayson,et al. Histopathologic features and MIB-1 labeling indices in recurrent and nonrecurrent meningiomas. , 1999, Archives of pathology & laboratory medicine.
[15] B. Scheithauer,et al. The prognostic significance of MIB‐1, p53, and DNA flow cytometry in completely resected primary meningiomas , 1998, Cancer.
[16] 中洲 敏,et al. 計測方法によるMIB-1 staining indexの差 : 髄膜腫における検討 , 1998 .
[17] C. Madsen,et al. Ki-67 immunoreactivity in meningiomas--determination of the proliferative potential of meningiomas using the monoclonal antibody Ki-67. , 1997, Clinical neuropathology.
[18] Hsu,et al. MIB‐1(Ki‐67) index and transforming growth factor‐alpha (TGFα) immunoreactivity are significant prognostic predictors for meningiomas , 1998, Neuropathology and applied neurobiology.
[19] B. Scheithauer,et al. "Malignancy" in meningiomas: a clinicopathologic study of 116 patients, with grading implications. , 1999, Cancer.
[20] M. Khan,et al. The recurrence of intracranial meningiomas after surgical treatment. , 1983, Journal of neurosurgery.
[21] 森村 達夫. In situ analysis of cell kinetics in human brain tumors , 1990 .
[22] S. Nakasu,et al. Preoperative identification of meningiomas that are highly likely to recur. , 1999, Journal of neurosurgery.
[23] M. Fukui,et al. MIB1 staining index and scoring of histologic features in meningioma. Indicators for the prediction of biologic potential and postoperative management , 1994, Cancer.